Urgent call for mass immunization against coronavirus in Bangladesh

Bangladesh showed initial success in the mass inoculation drive. However, the program was going through an alarming situation when the serum institute of India halted the shipments. Now the authority is administering US Moderna vaccines, Chinese Sinopharm vaccines, and Pfizer vaccines. Mass immunization is the only way for Bangladesh besides the present COVID-19 responses. Therefore, Bangladesh can utilize its previous experience in the roll-out of mass vaccination. The country can search for all available alternatives of COVID-19 vaccines besides maintaining diplomatic consistency with the existing sources for early vaccination of its population. The authority can try to get the committed vaccines from the COVAX program. Also, the country needs to maintain diplomatic relations with other global alliances that are promising support to poor and developing countries for the COVID-19 vaccine. The government can also consider direct purchases from vaccine manufacturers.

[1]  Md. Rabiul Islam,et al.  The “Delta Plus” COVID-19 variant has evolved to become the next potential variant of concern: mutation history and measures of prevention , 2021, Journal of basic and clinical physiology and pharmacology.

[2]  Md. Rakib Hasan,et al.  A nationwide dataset on the mental health of the Bangladeshi population due to the COVID-19 pandemic , 2021, Data in Brief.

[3]  M. Bhuiyan,et al.  Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID‐19 pandemic: Associated risk factors and preventive measures , 2021, Journal of medical virology.

[4]  Md. Jamal Hossain,et al.  Increments of gender‐based violence amid COVID‐19 in Bangladesh: A threat to global public health and women’s health , 2021, The International journal of health planning and management.

[5]  M. Asaduzzaman,et al.  Bangladesh reported delta variant of coronavirus among its citizen: Actionable items to tackle the potential massive third wave , 2021, Infection Prevention in Practice.

[6]  Md. Rabiul Islam,et al.  Mucormycosis or black fungus is a new fright in India during covid-19 pandemic: Associated risk factors and actionable items , 2021, Public Health in Practice.

[7]  M. Asaduzzaman,et al.  The massive attack of COVID‐19 in India is a big concern for Bangladesh: The key focus should be given on the interconnection between the countries , 2021, The International journal of health planning and management.

[8]  Md. Rabiul Islam,et al.  Effect of COVID-19 pandemic on mental health among Bangladeshi healthcare professionals: A cross-sectional study , 2021, Science progress.

[9]  Md. Rakib Hasan,et al.  Impact of COVID-19 pandemic on mental health among general Bangladeshi population: a cross-sectional study , 2021, BMJ Open.

[10]  Md. Jamal Hossain,et al.  Social Stigma and Suicide in Bangladesh: The Covid-19 has Worsened the Situation , 2021, Chronic stress.